B. Metzler seel. Sohn & Co. AG Has $4.12 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

B. Metzler seel. Sohn & Co. AG lifted its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,719 shares of the company's stock after buying an additional 1,210 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in HCA Healthcare were worth $4,118,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter worth $39,000. Activest Wealth Management lifted its holdings in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its holdings in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares during the period. Institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on HCA shares. JPMorgan Chase & Co. restated a "neutral" rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. KeyCorp lowered their price target on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley decreased their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $385.67.

Remove Ads

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Performance

NYSE:HCA traded up $1.75 during midday trading on Wednesday, reaching $347.48. The stock had a trading volume of 1,249,318 shares, compared to its average volume of 1,349,682. The stock has a market capitalization of $85.55 billion, a P/E ratio of 15.82, a PEG ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The firm's fifty day simple moving average is $326.35 and its 200-day simple moving average is $340.30.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the business posted $5.90 earnings per share. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.